Streetbeat News

Partnerships

ARKK

META

NVDA

TSLA

Spot Bitcoin ETFs experienced a $35M net inflow on their first trading day post-halving, with Ark Invest predicting a significant rally for Bitcoin. Trump criticized Biden for allegedly favoring Meta, while US markets saw mixed results and political tensions continue. Nvidia's chips reached China despite a US ban, and Microsoft challenges OpenAI with a new AI model. Tesla faces scrutiny over its growth strategy and advertising, while Boeing deals with production and safety challenges. Visa and UBS Group are making strategic financial moves, and California celebrates a renewable energy milestone.

Portfolio Pulse from Akanksha Bakshi

April 23, 2024 | 12:15 pm

AMZN

AVGO

ERIC

HACK

TRFK

Broadcom Inc faces criticism over its cloud licensing practices, with EU trade groups demanding an investigation despite recent revisions. Critics, including CISPE members like Amazon and other EU cloud providers, argue that Broadcom's changes to VMware's licensing terms fail to address concerns over price increases and unfair practices. Meanwhile, Oppenheimer analyst Rick Schafer highlights Broadcom as a top semiconductor pick, citing its expanding earnings and technology leadership. Broadcom's stock has seen significant growth, and exposure to it can be gained through ETFs like TRFK and HACK.

Portfolio Pulse from Anusuya Lahiri

April 23, 2024 | 12:13 pm

JHX

James Hardie has invited football legends Warren Sapp and Rondé Barber to participate in the inaugural James Hardie Pro Football Hall of Fame Invitational. This event highlights the company's engagement in high-profile sports marketing and community involvement.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:09 pm

IYT

TPOR

UPS

UPS reported mixed Q1 FY24 results with a 5.3% Y/Y revenue decline to $21.7 billion, missing consensus estimates. Adjusted EPS fell to $1.43 from $2.20 but beat the $1.30 consensus. Operating profit dropped significantly, with declines across all segments. Despite this, UPS maintains its 2024 outlook, expecting $92-$94.5 billion in revenue. The company also announced a significant air cargo contract with USPS. UPS shares rose 0.30% in premarket trading. Exposure to UPS can be gained through IYT and TPOR ETFs.

Portfolio Pulse from Lekha Gupta

April 23, 2024 | 12:08 pm

OOMA

3Phase has chosen Ooma's AirDial as a solution for replacing traditional Plain Old Telephone Service (POTS) lines, indicating a strategic move towards modernizing communication infrastructure.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:07 pm

FOUR

The Chicago White Sox have expanded their partnership with Shift4 to include ticketing payments. This enhancement of their collaboration signifies a deeper integration of Shift4's payment processing solutions within the White Sox's operational framework, potentially increasing transaction efficiency and customer satisfaction at their events.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:04 pm

VNRX

VolitionRx has announced that its Nu.Q Vet Cancer Test is now available for in-clinic use across the US and Europe through a partnership with Antech. This expansion could significantly impact VolitionRx's market presence and revenue streams, as it makes its innovative cancer detection technology more accessible to veterinarians and pet owners.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:03 pm

PDSB

PDS Biotech announced an event on May 8 to discuss positive, updated data from the Phase 2 VERSATILE-002 clinical trial of Versamune HPV in combination with KEYTRUDA for treating recurrent or metastatic head and neck cancer. The event will also cover unmet treatment needs in advanced head and neck cancer and plans for a triple combination trial.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 12:01 pm

CYN

Cyngn's stock is trading higher following the announcement that it will supply DriveMod Tuggers for industrial automation to John Deere's Dubuque, Iowa operation.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:37 am

THAR

Tharimmune has entered into an option agreement for an exclusive license with Washington University in St. Louis for technology related to multiple hybridomas and antibodies directed specifically towards human HER2. This agreement could potentially enhance Tharimmune's portfolio in targeted therapies for cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:36 am